Share this page:

Accel-Amplicon™ CFTR Panel

Targeted Sequencing for Cystic Fibrosis

Comprehensive. Fast. Lowest Input.

The Accel-Amplicon CFTR Panel offers a comprehensive approach to screen disease-relevant mutations and variants in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. This simple, rapid, and complete assay is tailored for clinical researchers and reference laboratories who discover, confirm, and screen common and rare mutations in the CFTR gene. This unique panel utilizes 87 amplicons covering all exons, including 5’ and 3’ UTRs and regions of interest in introns 1, 12, 22, and 25. It also captures all ACMG-recommended mutations, as well as offers a standardized solution to identify additional variants.

The CFTR panel generates targeted libraries compatible with Illumina® sequencing platforms, and is a complete kit that includes all components necessary for generating ready-to-sequence libraries, including primer pairs and indexed sequencing adapters.

Features:

  • Comprehensive coverage of CFTR gene
  • Single-tube assay
  • Ready-to-sequence libraries in 2 hours
  • Inputs as low as 10 ng
  • Compatible with multiple sample types
  • > 95% on-target specificity and coverage uniformity

Benefits:

  • Discovers and detects novel, known, and rare variants
  • Covers 100% ACMG-recommended mutations
  • Coverage of all exons, including 5’ and 3’ UTRs, and regions of interest in introns 1, 12, 22, and 25
  • Simple, easy-to-use workflow to minimize sample tracking errors
  • Prepare 3-4x more samples per day
  • Works with precious samples
  • Standardized assay for genomic DNA from whole blood, dried blood spot (DBS), saliva and buccal swabs
  • Captures poly-T tracts in concordance with the Sanger sequencing method

The Accel-Amplicon workflow uses an easy, fast, single-tube approach consisting of a 70-minute target enrichment amplification step and a 20-minute adapter ligation step, yielding a 2-hour start-to-finish procedure.

The single-tube workflow includes two brief incubations to generate the multiplex amplicon targets and add a unique combination of Illumina-compatible indexed adapters, creating up to 96 uniquely-indexed libraries for multiplexing on a single sequencing run.

Decrease Input, Not Sensitivity

The Accel-Amplicon CFTR Panel offers highly sensitive variant detection from input amounts as little as 10 ng. The kit utilizes Illumina-compatible, dual-indexed adapter sequences and has been validated on the MiniSeq® and MiSeq® platforms.

*Requires custom solution. Please inquire.

Performance on Illumina Platform

The data below demonstrate the performance of the Accel-Amplicon CFTR Panel on diverse ethnic backgrounds.

The Accel-Amplicon CFTR Panel was used to prepare libraries from 10 ng input of high quality Coriell (NA00897, NA11496, NA12878, NA19240, NA24143 and NA24695) gDNA.  Sequencing was performed using MiniSeq Reagents.

Coverage Uniformity CFTR

The Accel-Amplicon CFTR Panel provides high coverage uniformity across amplicons and was used to prepare libraries using 10 ng input of high quality Coriell NA11496 gDNA. Representative plot demonstrates amplicon coverage normalized to mean. Red and blue dashed lines represent 20% mean coverage and 5x mean coverage.

Variant Calling by Accel-Amplicon CFTR Panel

The Accel-Amplicon CFTR Panel detected ACMG-recommended variants (in bold) and other key variants in libraries prepared from 10-30 ng of DNA from DBS. The variants were called by FreeBays and GATK HaplotypeCaller (Broad Institute). The Accel-Amplicon CFTR Panel covers all exons, 5’ and 3’ UTRs, and regions of interest in introns 1, 12, 22, and 25 for the CFTR gene. Abbreviations: ACMG, American College of Medical Genetics; CF, cystic fibrosis; CFTR, CF transmembrane regulator; CR, conditionally reported with an R117H present; ND, not distinguishable. +* mutations assayed but detectable by method. Boldface entries indicate ACMG mutations.
Adopted from Hendrix et. al. Journal of Inborn Errors of Metabolism & Screening. 2016, Volume 4: 1–11
DOWNLOAD ARTICLE

The level of multiplexing is directly correlated to the size of the specific Accel-Amplicon Panel and the flow cell chemistry utilized for sequencing of the libraries. The table below provides an example of the number of libraries from the Accel-Amplicon Comprehensive TP53 and 56G Oncology Panels which can be multiplexed on a single MiSeq® flow cell. Accel-Amplicon panels currently include up to 96 indexing combinations and are consistently increasing.

*Please inquire by email to Tech Support if you require more than 96 unique indices.

Amplicon_Table_Level of Multiplexing

Lower than expected yields most likely relate to the quality and quantity of the sample, as well as how it was quantified. If possible, for severely compromised samples including FFPE, use 25 ng of qPCR-quantified input and extend the incubation time for the Indexing Step from 20 minutes to 60 minutes to improve yields. It is very important to quantify cfDNA or FFPE with qPCR as opposed to Qubit or NanoDrop to ensure there is a minimum of 10 ng of amplifiable content in the sample.

It is not recommended to use a Bioanalyzer or Qubit for quantifying libraries because there is no PCR enrichment of the library following the Indexing Step, so the Bioanalyzer or Qubit will not accurately quantify fully adapted library vs. other DNA. In addition, the Accel-Amplicon library adapters have secondary structure which exhibit migration artifacts on the Bioanalyzer.

Low cluster density is typically related to an error in library quantification. If the final library is quantified by methods other than qPCR, this will lead to determining an inaccurate value for library concentration. It is not recommended to use a Bioanalyzer or Qubit for quantifying libraries because there is no PCR enrichment of the library following the Indexing Step, so the Bioanalyzer or Qubit will not accurately quantify fully adapted library vs. other DNA.

In addition, the Accel-Amplicon library adapters have secondary structure which exhibit migration artifacts on the Bioanalyzer. When diluting the library for loading the flow cell and sequencing, if the dilution is based off an erroneous quantification the cluster density will not be optimal.

Swift is pleased to accept custom Accel-Amplicon Panel requests. We will use a custom design pipeline to generate the primer pools and provide a functionally-tested pilot kit, with pricing decided on a case-by-case basis dependent on reaction volumes and assay complexity. Please contact us by email at Tech Support and specify:

  • Number of genes to cover, with gene symbols
  • Hotspot (i.e., SNP) or whole-gene coverage requirements
  • Sample type(s) to be used with the custom panel such as FFPE, cfDNA, or high quality gDNA
  • Expected number of reactions required for the custom panel

There are multiple factors which determine the LOD, the most important being the number of copies of the variant-containing DNA actually present in the sample and the depth of sequencing performed.

There is also some variation in the reasonable LOD depending on the variant of interest. In general, the Accel-Amplicon technology is capable of a LOD down to 1% for most base substitution variants when working with 10-25 ng input DNA as quantified by a qPCR input assay.

It is very important to quantify cfDNA or FFPE with qPCR as opposed to Qubit or Nanodrop to ensure there is a minimum of 10 ng of amplifiable content in the sample for this LOD to be achieved, since for 10 ng this will be represented by ~30 mutant copies detected in ~3000 total copies.

It is also critical to achieve adequate sequencing depth to obtain sufficient mutant copy number detection. The table below illustrates observable allele frequencies for Accel-Amplicon libraries at 10 ng and 1 ng input amounts.

Please note that Swift Biosciences currently supports inputs down to 10 ng.

Amplicon_Table_Allele Frequencies

For maximal (lowest) LOD, increasing the input amount to 25 ng, if possible, will provide more confidence due to increased copy number ( > 6000 total copies and therefore > 60 copies of a 1% variant).

It is also important to note that the LOD inherent in Illumina technology can be discussed in terms of bases rated at Q30. Most bases are read with a rate of 1 error in 1000, or 0.1%. Some bases have a lower quality score and therefore the background false positive noise level is between 0.1-0.6%.

Using a base quality filter during the variant calling steps is one way to address this issue.

Swift does not currently offer a proprietary data analysis software package. Please view our technical note “Accel-Amplicon Panels: Bioinformatics Guidelines“, which includes a tutorial for using open-source Linux-based tools to perform the required primer trimming step, as well as general recommendations for the alignment and variant calling analysis.

While this can be caused by multiple factors, one of the most common explanations is that the Sample Sheet was not set to automatically trim the Illumina adapter sequences when generating the FASTQs prior to the primer trimming requirement of Accel-Amplicon Panels.

Make sure that the “Use adapter trimming” and “Use adapter trimming Read 2” are selected during the sample sheet setup. It is possible to re-run this analysis even after the sequencing run has been performed if these selections were not made during the initial sample sheet setup.

Place Order

First, select a product and quantity:

Catalog No. Description Price QTY
AL-55048 Accel-Amplicon CFTR Panel (48 rxns) $1680.00

$1,680.00Add to cart

The below solution is included with your product. If you require extra, please add now:

Catalog No. Description Price QTY
90196  PEG NaCl Solution (96 rxns) $20.00

$20.00Add to cart